Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Prevention proves cheaper than treatment for Li-Fraumeni syndrome

15

Jun 2026

Prevention proves cheaper than treatment for Li-Fraumeni syndrome

Screening people with the rare, inherited cancer-causing condition Li-Fraumeni syndrome (LFS) brings both medical and economic benefits to patients and healthcare systems, according to research to be presented to the annual conference of the European Society of Human Genetics today (Tuesday).

Migraine affects driving more often than clinicians may realize

15

Jun 2026

Migraine affects driving more often than clinicians may realize

A multicenter study of 1,333 active drivers with migraine found that 70.6% had experienced headache while driving, with headaches occurring during about 13% of driving sessions. The findings suggest that migraine-related symptoms may impair attention, increase sensitivity to road conditions, and contribute indirectly to driving cessation and accident risk.

Bionic cooling skin accelerates healing and combats wound infections

15

Jun 2026

Bionic cooling skin accelerates healing and combats wound infections

As the global burden of infected wounds continues to rise-with over 300 million surgeries performed annually and postoperative infections affecting 5–20% of patients-conventional wound dressings face a critical limitation: no single product has successfully integrated protective function, wearing comfort, and efficient antibacterial activity.

Persistent anxiety and depression may delay emotional maturity into midlife

15

Jun 2026

Persistent anxiety and depression may delay emotional maturity into midlife

A long-running Australian cohort study found that personality traits generally matured from early to middle adulthood, with agreeableness and conscientiousness rising and extraversion, openness, and neuroticism declining. People with persistent common mental disorders showed the clearest decline in neuroticism by midlife, but they still had higher emotional instability than peers without persistent mental health difficulties.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.